Project Details
Description
A Study to Characterize the Genetic, Biomarker, and Clinical Profile of Patients with Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)
Status | Finished |
---|---|
Effective start/end date | 12/12/19 → 9/30/20 |
Funding
- GOLDFINCH BIO
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.